NGVT

Ingevity Corp

Chemicals & Allied Products · SIC 2800CIK 1653477Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

Revenue FY2025

$1.17B

Net Income FY2025

$(0.17B)

EPS (Basic, as reported)

$-4.61

Net Margin FY2025

-14.3%

ROE FY2025

-562.6%

Total Equity

$0.03B

Shares Out

34M

Business description

Ingevity Corp — Chemicals & Allied Products. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2014–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions

default rows · click any row to chart itRevenue: 908 → 1,168 +2.8% CAGR

Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025

Revenue9089721,1341,2931,2161,3921,6681,6921,4061,168

Cost of revenue(634)(643)(717)(811)(751)(879)(1,098)(1,220)(952)(706)

Gross profit274329417482466513570472455462

Research & development(8)(20)(21)(20)(23)(26)(30)(32)(28)(28)

Selling, general & administrative(114)(106)(132)(163)(149)(179)(199)(184)(167)(171)

Operating income164202264397398422453397369419

Interest expense(19)(18)(33)(55)(47)(52)(62)(93)(98)(78)

Interest & investment income1238548685

Other income (expense), net30(1)44(80)2(6)(170)(25)

Pre-tax income87175222228235163270(10)(536)(142)

Income tax expense(43)(30)(40)(44)(54)(45)(58)(5)(105)(8)

Net income35127169184181118212(5)(430)(167)

EPS — basic$0.83$3.00$4.02$4.39$4.39$2.97$5.54($0.15)($11.85)($4.61)

EPS — diluted$0.83$2.97$3.97$4.35$4.37$2.95$5.50($0.15)($11.85)($4.61)

Shares outstanding — basic (M)42424242414038363636

Shares outstanding — diluted (M)42434342424038363636

Showing the latest 10 of 12 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.